Jason, Leonard A, McManimen, Stephanie, Sunnquist, Madison et al. · Journal of neurology and psychology · 2015
This study compared two different sets of diagnostic criteria for ME/CFS: one proposed by the Institute of Medicine for clinical use, and another (the Canadian criteria) recommended for research. Using patient data from the US, UK, and Norway, researchers found that patients meeting the research criteria were significantly more severely affected across multiple symptoms and daily functioning areas. This suggests the two criteria sets identify somewhat different groups of patients.
Case definitions directly affect which patients receive diagnoses, access treatment, and qualify for research studies. This study reveals that the criteria used can substantially alter who is identified as having ME/CFS and their apparent disease severity, with important implications for clinical practice, healthcare resource allocation, and research recruitment.
This study does not prove which criteria are more accurate or clinically useful—it only documents differences between groups. The cross-sectional design cannot establish causal relationships or explain why the research criteria identified more severely affected patients. It also does not address whether either criteria set captures the biological mechanisms underlying ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.